Also see: Juniper, PetSmart: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES

AK Steel ( AKS) numbers lowered at Goldman. Shares of AKS now seen reaching $12, according to Goldman Sachs. Estimates also cut, as costs continue to rise. Sell rating.

Affiliated Managers Group ( AMG) estimates, target increased at Citigroup. Shares of AMG now seen reaching $125. Estimates also raised on higher EPS and flow visibility. Buy rating.

Amazon.com ( AMZN) target raised at Morgan Stanley. Shares of AMZN now seen reaching $275, according to Morgan Stanley. Company continues to see solid sales growth across the board. Overweight rating.

Amazon.com estimates, target adjusted at UBS. Shares of AMZN now seen reaching $215 on accelerating demand, according to UBS. Estimates lowered through 2012. Neutral rating.

Anadarko ( APC) numbers raised at Goldman. Shares of APC now seen reaching $100. Estimates also increased, given a better exploration outlook. Neutral rating.

Anadarko estimates, target raised at Citigroup. Shares of APC now seen reaching $100. Estimates also raised on heightened catalyst potential and attractive valuation. Buy rating.

Biogen Idec ( BIIB) numbers boosted at Jefferies. Shares of BIIB now seen reaching $120. Estimates also upped, given higher Tysabri expectations. Buy rating.

Centene ( CNC) estimates, target increased at Goldman. CNC estimates were raised through 2012. Company has a strong growth pipeline. Neutral rating and new $41 price target.

Covidien ( COV) estimates, target adjusted at Citigroup. COV price target lowered to $64 on pressure on the peer group's multiple, according to Citigroup. Estimates increased through 2012. Buy rating.

DSW ( DSW) estimates, target increased at Citigroup. Shares of DSW now seen reaching $62. Estimates also increased on growth in the leased division and owned units. Buy rating.

Electronic Arts ( ERTS) estimates, target raised at UBS. Shares of ERTS now seen reaching $29.50. Estimates also raised on strong pre-orders for important games. Buy rating.

Ford ( F) estimates lowered at UBS through 2011 to reflect less inventory restocking. Maintain $22 price target and Buy rating.

Gilead ( GILD) estimates, target upped at Oppenheimer. GILD estimates were boosted through 2012. Company is seeing higher HIV sales. Outperform rating and new $46 price target.

If you liked this article you might like

North Korea Leader Kim Jong Un Warrants Your Attention, Silly Investor

Domino's Pizza CEO Thinks Self Driving Cars Will Deliver Pizza in 10 Years

Domino's Pizza CEO: In 10 Years,Self-Driving Cars Will Deliver Pizza

Your Guide to Making a Lot of Money on the Driverless Car Boom